These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 10730869

  • 1. A structure-activity study of a C-terminal endothelin analogue.
    Cassano E, Galoppini C, Giusti L, Hamdan M, Macchia M, Mazzoni MR, Menchini E, Pegoraro S, Rovero P.
    Folia Biol (Praha); 1998; 44(1):11-4. PubMed ID: 10730869
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological profile of ZD1611, a novel, orally active endothelin ETA receptor antagonist.
    Wilson C, Hunt SJ, Tang E, Wright N, Kelly E, Palmer S, Heys C, Mellor S, James R, Bialecki R.
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1085-91. PubMed ID: 10454481
    [Abstract] [Full Text] [Related]

  • 3. Toward the rational development of peptidomimetic analogs of the C-terminal endothelin hexapeptide: development of a theoretical model.
    Macchia M, Barontini S, Ceccarelli F, Galoppini C, Giusti L, Hamdan M, Lucacchini A, Martinelli A, Menchini E, Mazzoni MR, Revoltella RP, Romagnoli F, Rovero P.
    Farmaco; 1998 Sep; 53(8-9):545-56. PubMed ID: 10081817
    [Abstract] [Full Text] [Related]

  • 4. Structure-activity analysis of C-terminal endothelin analogues.
    Rovero P, Galoppini C, Laricchia-Robbio L, Mazzoni MR, Revoltella RP.
    J Cardiovasc Pharmacol; 1998 Sep; 31 Suppl 1():S251-4. PubMed ID: 9595452
    [Abstract] [Full Text] [Related]

  • 5. D-amino acid scan of endothelin: importance of amino acids adjacent to cysteinyl residues in isomeric selectivity.
    Galantino M, de Castiglione R, Cristiani C, Vaghi F, Liu W, Zhang JW, Tam JP.
    Pept Res; 1995 Sep; 8(3):154-9. PubMed ID: 7670230
    [Abstract] [Full Text] [Related]

  • 6. Biological and molecular analyses of structurally reduced analogues of endothelin-1.
    Forget MA, Lebel N, Sirois P, Boulanger Y, Fournier A.
    Mol Pharmacol; 1996 Jun; 49(6):1071-9. PubMed ID: 8649345
    [Abstract] [Full Text] [Related]

  • 7. A new endothelin C-terminal analogue IBDP 064 antagonizes endothelin-3-induced cell proliferation.
    Sedo A, Pegoraro S, Rovero P, Revoltella RP.
    Folia Biol (Praha); 1995 Jun; 41(2):97-105. PubMed ID: 7656997
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and structure-activity relationship studies of new endothelin pseudopeptide analogues containing alkyl spacers.
    Galoppini C, Giusti L, Macchia M, Hamdan M, Mazzoni MR, Calvani F, Rovero P.
    Farmaco; 1999 Apr 30; 54(4):213-7. PubMed ID: 10384713
    [Abstract] [Full Text] [Related]

  • 9. Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.
    Cody WL, He JX, Reily MD, Haleen SJ, Walker DM, Reyner EL, Stewart BH, Doherty AM.
    J Med Chem; 1997 Jul 04; 40(14):2228-40. PubMed ID: 9216842
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Endothelin-1 induces mucosal mast cell degranulation and tissue injury via ETA receptors.
    Boros M, Szalay L, Kaszaki J.
    Clin Sci (Lond); 2002 Aug 04; 103 Suppl 48():31S-34S. PubMed ID: 12193049
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Structure-activity relationships of N2-aryl-3-(isoxazolylsulfamoyl)-2-thiophenecarboxamides as selective endothelin receptor-A antagonists.
    Wu C, Chan MF, Stavros F, Raju B, Okun I, Castillo RS.
    J Med Chem; 1997 May 23; 40(11):1682-9. PubMed ID: 9171877
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Azole endothelin antagonists. 2. Structure-activity studies.
    von Geldern TW, Kester JA, Bal R, Wu-Wong JR, Chiou W, Dixon DB, Opgenorth TJ.
    J Med Chem; 1996 Feb 16; 39(4):968-81. PubMed ID: 8632420
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Structure-activity studies of endothelin leading to novel peptide ETA antagonists.
    Hunt JT, Lee VG, McMullen D, Liu EC, Bolgar M, Delaney CL, Festin SM, Floyd DM, Hedberg A, Natarajan S.
    Bioorg Med Chem; 1993 Jul 16; 1(1):59-65. PubMed ID: 8081838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.